Patents in the Pharmaceutical Sector: The Case of Developing Countries

&
Emerging Global Business Ethics (forthcoming)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,100

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
Pharmaceutical innovation and the burden of disease in developing and developed countries.Frank R. Lichtenberg - 2005 - Journal of Medicine and Philosophy 30 (6):663 – 690.
Fostering Labor Rights in Developing Countries: An Investors' Approach to Managing Labor Issues. [REVIEW]Robert H. Montgomery & Gregory F. Maggio - 2009 - Journal of Business Ethics 87 (1):199 - 219.
Patents and access to drugs in developing countries: An ethical analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
Energy charter treaty's investor protection provisions: Potential to Foster solutions to global warming and promote sustainable development.Edna Sussman - manuscript
Agents, vendors, and farmers: Public and private sector extension in agricultural development. [REVIEW]L. Van Crowder - 1987 - Agriculture and Human Values 4 (4):26-31.
Should patents for antiretrovirals be waived in the developing world? Annual varsity medical debate - London, 21 January 2011.Fenella Corrick, Robert Watson & Sanjay Budhdeo - 2011 - Philosophy, Ethics, and Humanities in Medicine 6:1-6.
Intellectual Property and Pharmaceutical Drugs.Richard T. De George - 2005 - Business Ethics Quarterly 15 (4):549-575.
Pharmaceutical companies and access to medicines – social integration and ethical CSR resolution of a global public choice problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
WARF's Stem Cell Patents and Tensions between Public and Private Sector Approaches to Research.John M. Golden - 2010 - Journal of Law, Medicine and Ethics 38 (2):314-331.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective.J. Cochrane - 2000 - Journal of Medical Ethics 26 (1):47-50.
Moral Obligation of Pharmaceutical Companies towards HIV Victims in Developing Countries.Azam Golam - 2008 - The Dhaka University Studies 64 (1):197-212.
Who's in the Business of Saving Lives?Pepe Lee Chang - 2006 - Journal of Medicine and Philosophy 31 (5):465-482.

Analytics

Added to PP
2014-01-27

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references